US2035401A
(en)
|
1933-10-21 |
1936-03-24 |
Dow Chemical Co |
Transportation of automobiles
|
US4360457A
(en)
*
|
1979-08-30 |
1982-11-23 |
Teijin Limited |
S-Sulfonated immunoglobulin composition having a high monomer content and a process for production thereof
|
US4374763A
(en)
*
|
1979-09-17 |
1983-02-22 |
Morishita Pharmaceutical Co., Ltd. |
Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof
|
NZ197553A
(en)
|
1980-07-01 |
1985-03-20 |
Nat Res Dev |
Production of antigens specific to r.s.v.;cell lines bearing these antigens and pharmaceutical compositions
|
DE3235924T1
(de)
|
1981-03-06 |
1983-05-05 |
Celltech Ltd., Slough, Berkshire |
Monoklonaler antikoerper
|
ATE37983T1
(de)
|
1982-04-22 |
1988-11-15 |
Ici Plc |
Mittel mit verzoegerter freigabe.
|
US4741900A
(en)
|
1982-11-16 |
1988-05-03 |
Cytogen Corporation |
Antibody-metal ion complexes
|
US5340926A
(en)
|
1983-03-25 |
1994-08-23 |
Celltech, Limited |
Process for the recovery of recombinantly produced protein from insoluble aggregate
|
FR2544567B1
(fr)
|
1983-04-15 |
1985-06-14 |
Thomson Csf |
Circuit generateur de dents de scie, en particulier pour balayage cathodique ligne par ligne
|
JPS60100516A
(ja)
|
1983-11-04 |
1985-06-04 |
Takeda Chem Ind Ltd |
徐放型マイクロカプセルの製造法
|
US5332805A
(en)
|
1984-02-03 |
1994-07-26 |
Celltech Limited |
Process for the recovery of recombinantly produced chymosin from insoluble aggregate
|
US4666884A
(en)
|
1984-04-10 |
1987-05-19 |
New England Deaconess Hospital |
Method of inhibiting binding of von Willebrand factor to human platelets and inducing interaction of platelets with vessel walls
|
US5128326A
(en)
|
1984-12-06 |
1992-07-07 |
Biomatrix, Inc. |
Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
|
US4597966A
(en)
|
1985-01-09 |
1986-07-01 |
Ortho Diagnostic Systems, Inc. |
Histidine stabilized immunoglobulin and method of preparation
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
US5017691A
(en)
|
1986-07-03 |
1991-05-21 |
Schering Corporation |
Mammalian interleukin-4
|
FR2590674B1
(fr)
|
1985-11-25 |
1989-03-03 |
Inst Nat Sante Rech Med |
Nouveaux reactifs de diagnostic
|
US5149650A
(en)
|
1986-01-14 |
1992-09-22 |
University Of North Carolina At Chapel Hill |
Vaccines for human respiratory virus
|
US4717766A
(en)
|
1986-01-27 |
1988-01-05 |
Miles Laboratories, Inc. |
Method of preparing high titer anti-respiratory syncytial virus intravenous immune globulin
|
US4659563A
(en)
|
1986-01-27 |
1987-04-21 |
Miles Laboratories, Inc. |
High titer anti-respiratory syncytial virus intravenous immune globulin
|
US5271927A
(en)
|
1986-02-13 |
1993-12-21 |
Celltech Limited |
Antibody conjugates with macrocyclic ligands
|
US5468606A
(en)
|
1989-09-18 |
1995-11-21 |
Biostar, Inc. |
Devices for detection of an analyte based upon light interference
|
EP0307434B2
(fr)
|
1987-03-18 |
1998-07-29 |
Scotgen Biopharmaceuticals, Inc. |
Anticorps alteres
|
DE3729863A1
(de)
*
|
1987-09-05 |
1989-03-16 |
Boehringer Mannheim Gmbh |
Stabilisierte erythropoietin-lyophilisate
|
US4800078A
(en)
|
1987-05-28 |
1989-01-24 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb
|
US4880078A
(en)
|
1987-06-29 |
1989-11-14 |
Honda Giken Kogyo Kabushiki Kaisha |
Exhaust muffler
|
GB8719041D0
(en)
|
1987-08-12 |
1987-09-16 |
Parker D |
Conjugate compounds
|
GB8720833D0
(en)
|
1987-09-04 |
1987-10-14 |
Celltech Ltd |
Recombinant dna product
|
US5223254A
(en)
|
1987-09-29 |
1993-06-29 |
Praxis Biologics, Inc. |
Respiratory syncytial virus: vaccines
|
US5336603A
(en)
|
1987-10-02 |
1994-08-09 |
Genentech, Inc. |
CD4 adheson variants
|
JP2716503B2
(ja)
|
1987-12-23 |
1998-02-18 |
ジ・アップジョン・カンパニー |
ヒト呼吸系シンシチウムウイルスの糖蛋白類の免疫原性セグメントを含有するキメラ糖蛋白類
|
JP3095168B2
(ja)
|
1988-02-05 |
2000-10-03 |
エル. モリソン,シェリー |
ドメイン‐変性不変部を有する抗体
|
US5183657A
(en)
|
1988-03-11 |
1993-02-02 |
Celltech Limited |
Antibodies for use in antilymphocyte antibody therapy
|
JPH01268646A
(ja)
|
1988-04-20 |
1989-10-26 |
Meiji Milk Prod Co Ltd |
抗腫瘍剤
|
US5137804A
(en)
|
1988-05-10 |
1992-08-11 |
E. I. Du Pont De Nemours And Company |
Assay device and immunoassay
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
KR900005995A
(ko)
|
1988-10-31 |
1990-05-07 |
우메모또 요시마사 |
변형 인터류킨-2 및 그의 제조방법
|
ES2052027T5
(es)
|
1988-11-11 |
2005-04-16 |
Medical Research Council |
Clonacion de secuencias de dominio variable de inmunoglobulina.
|
US5734033A
(en)
|
1988-12-22 |
1998-03-31 |
The Trustees Of The University Of Pennsylvania |
Antisense oligonucleotides inhibiting human bcl-2 gene expression
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
US5354554A
(en)
|
1989-02-10 |
1994-10-11 |
Celltech Limited |
Crosslinked antibodies and processes for their preparation
|
US6093872A
(en)
|
1989-05-05 |
2000-07-25 |
Systemix, Inc. |
Extended human hematopoiesis in a heterologous host
|
US5112946A
(en)
|
1989-07-06 |
1992-05-12 |
Repligen Corporation |
Modified pf4 compositions and methods of use
|
FR2650598B1
(fr)
|
1989-08-03 |
1994-06-03 |
Rhone Poulenc Sante |
Derives de l'albumine a fonction therapeutique
|
US5332567A
(en)
|
1989-08-24 |
1994-07-26 |
Immunomedics |
Detection and treatment of infections with immunoconjugates
|
US5518725A
(en)
|
1989-09-25 |
1996-05-21 |
University Of Utah Research Foundation |
Vaccine compositions and method for induction of mucosal immune response via systemic vaccination
|
IT1240314B
(it)
|
1989-09-28 |
1993-12-07 |
Immunobiology Research Institutes, Inc. |
Formulazioni acquose stabilizzate di piccoli peptidi.
|
WO1991005548A1
(fr)
|
1989-10-10 |
1991-05-02 |
Pitman-Moore, Inc. |
Composition a liberation entretenue pour proteines macromoleculaires
|
WO1991006570A1
(fr)
|
1989-10-25 |
1991-05-16 |
The University Of Melbourne |
MOLECULES RECEPTRICES Fc HYBRIDES
|
CA2071867A1
(fr)
|
1989-11-06 |
1991-05-07 |
Edith Mathiowitz |
Mode de fabrication de microspheres proteiniques
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
US5314995A
(en)
|
1990-01-22 |
1994-05-24 |
Oncogen |
Therapeutic interleukin-2-antibody based fusion proteins
|
US5279935A
(en)
|
1990-03-01 |
1994-01-18 |
Becton, Dickinson And Company |
Method of immunossay including deactivation of endogenous alkaline phosphatase
|
JP3319594B2
(ja)
|
1990-03-20 |
2002-09-03 |
ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク |
定常領域の代わりに受容体結合性リガンドを有するキメラ抗体
|
AU637914B2
(en)
|
1990-05-03 |
1993-06-10 |
Systemix, Inc. |
Human lymphoid tissue in an immunocompromised host
|
US5349053A
(en)
|
1990-06-01 |
1994-09-20 |
Protein Design Labs, Inc. |
Chimeric ligand/immunoglobulin molecules and their uses
|
GB9020282D0
(en)
|
1990-09-17 |
1990-10-31 |
Gorman Scott D |
Altered antibodies and their preparation
|
JP3242916B2
(ja)
|
1990-12-14 |
2001-12-25 |
セル ジェネシス,インコーポレイティド |
レセプター関連シグナル変換系のためのキメラ鎖
|
ATE161967T1
(de)
|
1991-04-22 |
1998-01-15 |
Massachusetts Health Res |
Verfahren für das screening von plasma-proben für einen effektiven antikörpernachweis gegen respiratorische viren
|
AU666852B2
(en)
|
1991-05-01 |
1996-02-29 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
A method for treating infectious respiratory diseases
|
CA2044940A1
(fr)
|
1991-06-10 |
1992-12-11 |
Inder M. Verma |
Proto-oncogene negatif transdominant
|
WO1993005796A1
(fr)
|
1991-09-19 |
1993-04-01 |
The Scripps Research Institute |
Procede de production d'anticorps humains dans un animal non humain, et animaux utilises a cet effet
|
US5240694A
(en)
|
1991-09-23 |
1993-08-31 |
University Of Virginia |
Combined antiviral and antimediator treatment of common colds
|
US5418136A
(en)
|
1991-10-01 |
1995-05-23 |
Biostar, Inc. |
Devices for detection of an analyte based upon light interference
|
US6162432A
(en)
|
1991-10-07 |
2000-12-19 |
Biogen, Inc. |
Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
|
DE4135070C1
(fr)
|
1991-10-24 |
1993-05-19 |
Institut Fuer Rundfunktechnik Gmbh, 8000 Muenchen, De |
|
ES2115683T3
(es)
|
1991-11-15 |
1998-07-01 |
Cornell Res Foundation Inc |
Inmunoensayo indirecto para detectar compuestos de tipo dioxina.
|
US20020102257A1
(en)
|
1998-09-21 |
2002-08-01 |
Leslie Sid Johnson |
Human-murine chimeric antibodies against respiratory syncytial virus
|
US5824307A
(en)
*
|
1991-12-23 |
1998-10-20 |
Medimmune, Inc. |
Human-murine chimeric antibodies against respiratory syncytial virus
|
US5622929A
(en)
|
1992-01-23 |
1997-04-22 |
Bristol-Myers Squibb Company |
Thioether conjugates
|
US5667988A
(en)
|
1992-01-27 |
1997-09-16 |
The Scripps Research Institute |
Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
|
FR2686901A1
(fr)
|
1992-01-31 |
1993-08-06 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides antithrombotiques, leur preparation et compositions pharmaceutiques les contenant.
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
US6271242B1
(en)
|
1992-02-10 |
2001-08-07 |
Bristol-Myers Squibb Co. |
Method for treating cancer using a tyrosine protein kinase inhibitor
|
IL104684A0
(en)
|
1992-02-14 |
1993-06-10 |
Bristol Myers Squibb Co |
The cd40cr receptor and ligands therefor
|
US5912015A
(en)
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
JPH07507923A
(ja)
|
1992-03-20 |
1995-09-07 |
イムネット |
ヒトモノクローナル抗体およびヒトモノクローナル抗体製造法
|
US5447851B1
(en)
|
1992-04-02 |
1999-07-06 |
Univ Texas System Board Of |
Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
|
GB9207479D0
(en)
|
1992-04-06 |
1992-05-20 |
Scotgen Ltd |
Novel antibodies for treatment and prevention of respiratory syncytial virus infection in animals and man
|
ZA932522B
(en)
|
1992-04-10 |
1993-12-20 |
Res Dev Foundation |
Immunotoxins directed against c-erbB-2(HER/neu) related surface antigens
|
AU4116793A
(en)
|
1992-04-24 |
1993-11-29 |
Board Of Regents, The University Of Texas System |
Recombinant production of immunoglobulin-like domains in prokaryotic cells
|
JPH08501085A
(ja)
|
1992-08-26 |
1996-02-06 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
抗腫瘍剤としてのサイトカインip−10の利用
|
ATE231002T1
(de)
|
1992-09-16 |
2003-02-15 |
Scripps Research Inst |
Menschliche, neutralisierende, monoklonale antikörper gegen das respiratorische synzytialvirus
|
US6685942B1
(en)
|
1993-12-10 |
2004-02-03 |
The Scripps Research Institute |
Human neutralizing monoclonal antibodies to respiratory syncytial virus
|
CA2153661A1
(fr)
|
1993-01-12 |
1994-07-21 |
Anthony George Gristina |
Methodes et compositions pour appliquer directement et de facon concentree une immunite passive
|
US5934272A
(en)
|
1993-01-29 |
1999-08-10 |
Aradigm Corporation |
Device and method of creating aerosolized mist of respiratory drug
|
US5424189A
(en)
|
1993-03-05 |
1995-06-13 |
Kansas State University Research Foundation |
Bovine respiratory syncytial virus detection and primers
|
JPH08511420A
(ja)
|
1993-06-16 |
1996-12-03 |
セルテック・セラピューテイクス・リミテッド |
抗 体
|
WO1995002420A2
(fr)
|
1993-07-15 |
1995-01-26 |
Cancer Research Campaign Technology Ltd. |
Bioprecurseurs d'inhibiteurs de la tyrosine-kinase de proteines
|
EP0724602A4
(fr)
|
1993-07-30 |
1998-12-23 |
Oravax Inc |
ANTICORPS IgA MONOCLONAL DIRIGE CONTRE LE VIRUS RESPIRATOIRE SYNCYTIAL
|
DE4344824C1
(de)
|
1993-12-28 |
1995-08-31 |
Immuno Ag |
Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
|
US5925376C1
(en)
|
1994-01-10 |
2001-03-20 |
Madalene C Y Heng |
Method for treating psoriasis using selected phosphorylase kinase inhibitor and additional compounds
|
US5618709A
(en)
|
1994-01-14 |
1997-04-08 |
University Of Pennsylvania |
Antisense oligonucleotides specific for STK-1 and method for inhibiting expression of the STK-1 protein
|
US5837458A
(en)
|
1994-02-17 |
1998-11-17 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
US5834252A
(en)
|
1995-04-18 |
1998-11-10 |
Glaxo Group Limited |
End-complementary polymerase reaction
|
US5605793A
(en)
|
1994-02-17 |
1997-02-25 |
Affymax Technologies N.V. |
Methods for in vitro recombination
|
US5538952A
(en)
|
1994-05-26 |
1996-07-23 |
Abbott Laboratories |
Inhibition of infection of mammalian cells by respiratory syncytial virus
|
US5506209A
(en)
|
1994-05-26 |
1996-04-09 |
Abbott Laboratories |
Product for inhibition of infection of mammalian cells by respiratory syncytial virus
|
US5538733A
(en)
|
1994-07-07 |
1996-07-23 |
Willmar Poultry Company, Inc. |
Method of priming an immune response in a one-day old animal
|
CN1117155C
(zh)
|
1994-07-29 |
2003-08-06 |
史密丝克莱恩比彻姆有限公司 |
新型化合物
|
US5792456A
(en)
|
1994-08-04 |
1998-08-11 |
Bristol-Myers Squibb Company |
Mutant BR96 antibodies reactive with human carcinomas
|
US5587459A
(en)
|
1994-08-19 |
1996-12-24 |
Regents Of The University Of Minnesota |
Immunoconjugates comprising tyrosine kinase inhibitors
|
US5911995A
(en)
|
1994-08-19 |
1999-06-15 |
Regents Of The University Of Minnesota |
EGF-genistein conjugates for the treatment of cancer
|
GB9418092D0
(en)
|
1994-09-08 |
1994-10-26 |
Red Cross Found Cent Lab Blood |
Organic compounds
|
WO1996020698A2
(fr)
|
1995-01-05 |
1996-07-11 |
The Board Of Regents Acting For And On Behalf Of The University Of Michigan |
Nanoparticules a modification de surface et leurs procedes de fabrication et d'utilisation
|
GB9501567D0
(en)
|
1995-01-26 |
1995-03-15 |
Pharmacia Spa |
Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
|
US5998596A
(en)
|
1995-04-04 |
1999-12-07 |
The United States Of America As Represented By The Department Of Health And Human Services |
Inhibition of protein kinase activity by aptameric action of oligonucleotides
|
US5747035A
(en)
|
1995-04-14 |
1998-05-05 |
Genentech, Inc. |
Polypeptides with increased half-life for use in treating disorders involving the LFA-1 receptor
|
US6019968A
(en)
|
1995-04-14 |
2000-02-01 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
US5739277A
(en)
|
1995-04-14 |
1998-04-14 |
Genentech Inc. |
Altered polypeptides with increased half-life
|
US6096871A
(en)
|
1995-04-14 |
2000-08-01 |
Genentech, Inc. |
Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
|
US6121022A
(en)
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
US5869046A
(en)
|
1995-04-14 |
1999-02-09 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
EP0841068B1
(fr)
|
1995-06-01 |
2006-07-12 |
Kishimoto, Tadamitsu |
Inhibiteur de la croissance de cellules leucemiques contenant des derives oligonucleotidiques antisens agissant contre le gene de la tumeur de wilms (wt1)
|
US5811524A
(en)
|
1995-06-07 |
1998-09-22 |
Idec Pharmaceuticals Corporation |
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
|
GB9515975D0
(en)
|
1995-08-04 |
1995-10-04 |
Zeneca Ltd |
Chemical compounds
|
CA2230494A1
(fr)
|
1995-08-31 |
1997-03-06 |
Alkermes Controlled Therapeutics Inc. |
Composition se pretant a la liberation prolongee d'un agent
|
ATE194291T1
(de)
|
1995-09-18 |
2000-07-15 |
Intracel Corp |
Neutralisierende monoklonale antikörper gegen respiratorischen synzytialvirus
|
US5863904A
(en)
|
1995-09-26 |
1999-01-26 |
The University Of Michigan |
Methods for treating cancers and restenosis with P21
|
US6127366A
(en)
|
1995-11-22 |
2000-10-03 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
DE69620445T2
(de)
|
1995-12-08 |
2002-12-12 |
Janssen Pharmaceutica Nv |
(imidazol-5-yl)methyl-2-chinolinoderivate als farnesyl protein transferase inhibitoren
|
US5958769A
(en)
|
1996-01-18 |
1999-09-28 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for mediating cell cycle progression
|
WO1997027852A1
(fr)
|
1996-01-30 |
1997-08-07 |
Merck & Co., Inc. |
Inhibiteurs de la farnesyle transferase
|
US6090948A
(en)
|
1996-01-30 |
2000-07-18 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
AU2063197A
(en)
|
1996-03-04 |
1997-09-22 |
Massachusetts Institute Of Technology |
Materials and methods for enhancing cellular internalization
|
AU5711196A
(en)
|
1996-03-14 |
1997-10-01 |
Human Genome Sciences, Inc. |
Apoptosis inducing molecule i
|
WO1997034631A1
(fr)
|
1996-03-18 |
1997-09-25 |
Board Of Regents, The University Of Texas System |
Domaines analogues a l'immunoglobuline a demi-vies prolongees
|
CA2248868A1
(fr)
|
1996-03-22 |
1997-09-25 |
Human Genome Sciences, Inc. |
Molecule ii inductrice d'apoptose
|
US5891889A
(en)
|
1996-04-03 |
1999-04-06 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5883105A
(en)
|
1996-04-03 |
1999-03-16 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US6063930A
(en)
|
1996-04-03 |
2000-05-16 |
Merck & Co., Inc. |
Substituted imidazole compounds useful as farnesyl-protein transferase inhibitors
|
US6080870A
(en)
|
1996-04-03 |
2000-06-27 |
Merck & Co., Inc. |
Biaryl substituted imidazole compounds useful as farnesyl-protein transferase inhibitors
|
WO1997043316A1
(fr)
|
1996-05-10 |
1997-11-20 |
Beth Israel Deaconess Medical Center, Inc. |
Molecules physiologiquement actives a demi-vies prolongees et methode d'utilisation de ces dernieres
|
US6300501B1
(en)
|
1996-05-22 |
2001-10-09 |
Warner-Lambert Company |
Histidine-(N-benzyl glycinamide) inhibitors of protein farnesyl transferase
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US5855913A
(en)
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
GB9610992D0
(en)
*
|
1996-05-24 |
1996-07-31 |
Glaxo Group Ltd |
Concentrated antibody preparation
|
US5985309A
(en)
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
US5648239A
(en)
|
1996-06-21 |
1997-07-15 |
Incyte Pharmaceuticals, Inc. |
Human camp-dependent protein kinase inhibitor homolog
|
BR9709974A
(pt)
|
1996-06-27 |
1999-08-10 |
Pfizer |
Derivados de 2-(2-oxo-etidileno)-imidazolidin-4-ona e seu uso como inibidores da transferase da proteina de farnesila
|
CA2263425C
(fr)
|
1996-08-12 |
2008-09-30 |
Yoshitomi Pharmaceutical Industries Ltd. |
Medicaments comprenant un inhibiteur de la rho kinase
|
US5945429A
(en)
|
1996-09-13 |
1999-08-31 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US6030982A
(en)
|
1996-09-13 |
2000-02-29 |
Schering Corporationm |
Compounds useful for inhibition of farnesyl protein transferase
|
US6040305A
(en)
|
1996-09-13 |
2000-03-21 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US5885834A
(en)
|
1996-09-30 |
1999-03-23 |
Epstein; Paul M. |
Antisense oligodeoxynucleotide against phosphodiesterase
|
WO1998023289A1
(fr)
|
1996-11-27 |
1998-06-04 |
The General Hospital Corporation |
Modulation de la fixation de l'igg au fcrn
|
US5961927A
(en)
|
1996-12-23 |
1999-10-05 |
Formatech, Inc. |
Working pipettor station
|
US5939439A
(en)
|
1996-12-30 |
1999-08-17 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US6093737A
(en)
|
1996-12-30 |
2000-07-25 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US6013662A
(en)
|
1996-12-30 |
2000-01-11 |
Rhone-Poulenc Rorer S.A. |
Farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments
|
FR2758331B1
(fr)
|
1997-01-14 |
1999-03-05 |
Univ Bourgogne |
Nouveaux moyens pour le diagnostic, la prevention et le traitement vis-a-vis de contaminations ou d'infections par des virus a tropisme muqueux
|
CA2277801C
(fr)
|
1997-01-16 |
2002-10-15 |
Massachusetts Institute Of Technology |
Preparation de particules pour inhalation
|
AU5772698A
(en)
|
1997-01-29 |
1998-08-18 |
Zeneca Limited |
Inhibitors of farnesyl protein transferase
|
US6590079B2
(en)
|
1997-01-30 |
2003-07-08 |
Ixsys, Incorporated |
Anti-αvβ3 recombinant human antibodies, nucleic acids encoding same
|
WO1998034594A1
(fr)
|
1997-02-06 |
1998-08-13 |
Merck & Co., Inc. |
Conservateurs sans thimerosal pour vaccins
|
ZA981080B
(en)
|
1997-02-11 |
1998-08-12 |
Warner Lambert Co |
Bicyclic inhibitors of protein farnesyl transferase
|
US6117980A
(en)
|
1997-02-21 |
2000-09-12 |
Genentech, Inc. |
Humanized anti-IL-8 monoclonal antibodies
|
US6277375B1
(en)
|
1997-03-03 |
2001-08-21 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
TW591030B
(en)
|
1997-03-10 |
2004-06-11 |
Janssen Pharmaceutica Nv |
Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
|
US6171586B1
(en)
|
1997-06-13 |
2001-01-09 |
Genentech, Inc. |
Antibody formulation
|
DE69810481T2
(de)
|
1997-06-13 |
2003-09-25 |
Genentech Inc |
Stabilisierte antikörperformulierung
|
US6211193B1
(en)
|
1997-06-17 |
2001-04-03 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US6225322B1
(en)
|
1997-06-17 |
2001-05-01 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US6239140B1
(en)
|
1997-06-17 |
2001-05-29 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US6051582A
(en)
|
1997-06-17 |
2000-04-18 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US6159984A
(en)
|
1997-06-17 |
2000-12-12 |
Schering Corporation |
Farnesyl protein transferase inhibitors
|
US6228865B1
(en)
|
1997-06-17 |
2001-05-08 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
UA61970C2
(en)
|
1997-08-15 |
2003-12-15 |
|
Combined use of tyrosine kinase inhibitor and a chemical castration agent for treating prostate cancer
|
US5989463A
(en)
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
US6103723A
(en)
|
1997-10-17 |
2000-08-15 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
ATE205195T1
(de)
|
1997-10-22 |
2001-09-15 |
Astrazeneca Ab |
Imidazolderivate und ihre verwendung als farnesylproteintransferase inhibitoren
|
US6410539B1
(en)
|
1997-10-22 |
2002-06-25 |
Astrazenca Uk Limited |
Imidazole derivatives and their use as farnesyl protein transferase inhibitors
|
SE512663C2
(sv)
|
1997-10-23 |
2000-04-17 |
Biogram Ab |
Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
|
EP1042343B1
(fr)
|
1997-11-03 |
2008-01-23 |
Human Genome Sciences, Inc. |
Vegi, un inhibiteur de l'angiogenese et de la croissance tumorale
|
US6124465A
(en)
|
1997-11-25 |
2000-09-26 |
Rhone-Poulenc S.A. |
Farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments
|
CA2310629A1
(fr)
|
1997-11-28 |
1999-06-10 |
Tae Hwan Kwak |
Derives d'imidazole a activite inhibitrice de farnesyle transferase et leur procede de preparation
|
EP1025230B1
(fr)
|
1997-12-01 |
2006-02-08 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
ANTICORPS, NOTAMMENT DES MOLECULES Fv, IMMUNOCONJUGUES PRESENTANT UNE GRANDE AFFINITE DE LIAISON POUR LA MESOTHELINE ET PROCEDES D'UTILISATION CORRESPONDANTS
|
US6054466A
(en)
|
1997-12-04 |
2000-04-25 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US6242196B1
(en)
|
1997-12-11 |
2001-06-05 |
Dana-Farber Cancer Institute |
Methods and pharmaceutical compositions for inhibiting tumor cell growth
|
US6335156B1
(en)
|
1997-12-18 |
2002-01-01 |
The Johns Hopkins University School Of Medicine |
14-3-3σ arrests the cell cycle
|
ES2185307T3
(es)
|
1998-02-02 |
2003-04-16 |
Lg Chemical Ltd |
Inhibidores de la farnesil transferasa que tienen una estructura piperidinica y procedimiento para su preparacion.
|
CZ20003099A3
(cs)
|
1998-02-25 |
2002-04-17 |
Lexigen Pharmaceuticals Corporation |
Zvýąení doby poloviční ľivotnosti cirkulujících fúzních proteinů odvozených od protilátek
|
EP1068241B1
(fr)
|
1998-04-02 |
2007-10-10 |
Genentech, Inc. |
Variants d'anticorps et fragments de ceux-ci
|
US6528624B1
(en)
|
1998-04-02 |
2003-03-04 |
Genentech, Inc. |
Polypeptide variants
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
JP2002513031A
(ja)
|
1998-04-27 |
2002-05-08 |
ワーナー−ランバート・カンパニー |
ファルネシルトランスフェラーゼ阻害剤としての機能化されたアルキルおよびアルケニル側鎖を有するグリシンアミド誘導体
|
WO1999066903A2
(fr)
|
1998-06-24 |
1999-12-29 |
Advanced Inhalation Research, Inc. |
Grandes particules poreuses emises par un inhalateur
|
HU229358B1
(en)
|
1998-07-06 |
2013-11-28 |
Janssen Pharmaceutica Nv |
Farnesyl protein transferase inhibitors for treating arthropathies
|
US6034053A
(en)
|
1998-07-13 |
2000-03-07 |
Wayne Hughes Institute |
EGF-isoflavone conjugates for the prevention of restenosis
|
CA2341029A1
(fr)
|
1998-08-17 |
2000-02-24 |
Abgenix, Inc. |
Production de molecules modifiees avec demi-vie serique prolongee
|
CA2341624C
(fr)
|
1998-08-25 |
2008-12-02 |
Advanced Inhalation Research, Inc. |
Formulations proteiques atomisees stables
|
US6572856B1
(en)
|
1998-09-10 |
2003-06-03 |
The University Of Virginia Patent Foundation |
Methods for the prevention and treatment of cancer using anti-C3b(i) antibodies
|
PT1135498E
(pt)
|
1998-11-18 |
2008-04-30 |
Genentech Inc |
Variantes de anticorpos com maior afinidade de ligação em comparação com os anticorpos parentais
|
US6372747B1
(en)
|
1998-12-18 |
2002-04-16 |
Schering Corporation |
Farnesyl protein transferase inhibitors
|
US6362188B1
(en)
|
1998-12-18 |
2002-03-26 |
Schering Corporation |
Farnesyl protein transferase inhibitors
|
FR2787327B1
(fr)
|
1998-12-21 |
2003-01-17 |
Aventis Pharma Sa |
Compositions contenant des inhibiteurs de farnesyle transferase
|
US6432959B1
(en)
|
1998-12-23 |
2002-08-13 |
Schering Corporation |
Inhibitors of farnesyl-protein transferase
|
JP4876239B2
(ja)
|
1999-01-11 |
2012-02-15 |
プリンストン ユニバーシティー |
標的確認のための高親和性阻害剤およびその使用
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
KR100940380B1
(ko)
|
1999-01-15 |
2010-02-02 |
제넨테크, 인크. |
효과기 기능이 변화된 폴리펩티드 변이체
|
US6399633B1
(en)
|
1999-02-01 |
2002-06-04 |
Aventis Pharmaceuticals Inc. |
Use of 4-H-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferation
|
US6245759B1
(en)
|
1999-03-11 |
2001-06-12 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
AR022952A1
(es)
|
1999-03-19 |
2002-09-04 |
Smithkline Beecham Corp |
ANTICUERPO MONOCLONAL DE ROEDOR ESPECIFICAMENTE NEUTRALIZANTE PARA LA INTERLEUQUINA-18 HUMANA , UN FRAGMENTO FAB NEUTRALIZANTE o FRAGMENTO F(AB')2, UNA REGION DE COMPLEMENTARIEDAD DE CADENA LIGERA DE INMONOGLOBULINA(CDR), UNA MOLECULA DE ACIDO NUCLEICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE, EL
|
US6143766A
(en)
|
1999-04-16 |
2000-11-07 |
Warner-Lambert Company |
Benzopyranone and quinolone inhibitors of ras farnesyl transferase
|
AU5303700A
(en)
|
1999-05-27 |
2000-12-18 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Immunoconjugates having high binding affinity
|
US6458935B1
(en)
|
1999-06-23 |
2002-10-01 |
Merck & Co., Inc. |
Radiolabeled farnesyl-protein transferase inhibitors
|
CA2382821A1
(fr)
|
1999-08-25 |
2001-03-01 |
Advanced Inhalation Research, Inc. |
Modulation de liberation a partir de formulations seches en poudre
|
US6586008B1
(en)
|
1999-08-25 |
2003-07-01 |
Advanced Inhalation Research, Inc. |
Use of simple amino acids to form porous particles during spray drying
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
US6403581B1
(en)
|
2000-01-19 |
2002-06-11 |
American Cyanamid Company |
Method of inhibition of farnesyl-protein transferase using substituted benz (cd) indol-2-imine and-amine derivatives
|
US7229619B1
(en)
|
2000-11-28 |
2007-06-12 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
ES2349348T3
(es)
|
2000-01-27 |
2010-12-30 |
Medimmune, Llc |
Anticuerpos neutralizantes de rsv de ultra alta afinidad.
|
US20010034062A1
(en)
|
2000-02-09 |
2001-10-25 |
Scott Koenig |
Antibody gene therapy with adeno-associated viral vectors
|
CA2399832C
(fr)
|
2000-02-11 |
2011-09-20 |
Stephen D. Gillies |
Amelioration de la demi-vie circulante de proteines de fusion a base d'anticorps
|
CA2401652A1
(fr)
*
|
2000-03-01 |
2001-09-07 |
Medimmune, Inc. |
Anticorps de recombinaison hautement efficaces et procede de production de ceux-ci
|
AU2001241918A1
(en)
|
2000-03-02 |
2001-09-12 |
Med Immune, Inc. |
Methods of enhancing activity of vaccines and vaccine compositions
|
EP2267026A1
(fr)
|
2000-04-12 |
2010-12-29 |
Human Genome Sciences, Inc. |
Protéine de fusion d'albumine
|
IL151348A0
(en)
|
2000-04-13 |
2003-04-10 |
Univ Rockefeller |
Enhancement of antibody-mediated immune responses
|
AU2001259379B2
(en)
|
2000-05-03 |
2006-08-03 |
Medimmune, Llc |
Combination therapy of respiratory diseases using antibodies
|
EP1278546B1
(fr)
|
2000-05-03 |
2010-02-10 |
Medimmune, LLC |
Polytherapie pour maladies respiratoires, dans laquelle des anticorps et des agents anti-inflammatoires sont utilises
|
ES2244515T3
(es)
|
2000-05-03 |
2005-12-16 |
Ipv Inheidener Produktions- Und Vertriebsgesellschaft Mbh |
Contenedor termico.
|
AU2001263443A1
(en)
|
2000-05-25 |
2001-12-03 |
Med Immune, Inc. |
F-protein epitope-based vaccine for respiratory syncytial virus infection
|
AU2001276737A1
(en)
|
2000-08-04 |
2002-02-18 |
Chugai Seiyaku Kabushiki Kaisha |
Protein injection preparations
|
JP5485489B2
(ja)
*
|
2000-08-11 |
2014-05-07 |
中外製薬株式会社 |
抗体含有安定化製剤
|
US6565888B1
(en)
|
2000-08-23 |
2003-05-20 |
Alkermes Controlled Therapeutics, Inc. |
Methods and compositions for the targeted delivery of biologically active agents
|
EP2027874B1
(fr)
|
2000-11-28 |
2013-10-16 |
Medimmune, Inc. |
Procédés d'administration/dosage d'anticorps anti-rsv pour la prophylaxie et le traitement
|
US7179900B2
(en)
|
2000-11-28 |
2007-02-20 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
US6855493B2
(en)
|
2000-11-28 |
2005-02-15 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
US6818216B2
(en)
|
2000-11-28 |
2004-11-16 |
Medimmune, Inc. |
Anti-RSV antibodies
|
ES2649037T3
(es)
|
2000-12-12 |
2018-01-09 |
Medimmune, Llc |
Moléculas con semividas prolongadas, composiciones y usos de las mismas
|
US7658921B2
(en)
|
2000-12-12 |
2010-02-09 |
Medimmune, Llc |
Molecules with extended half-lives, compositions and uses thereof
|
AU2002250236A1
(en)
|
2001-03-02 |
2002-09-19 |
Medimmune, Inc. |
Cd2 antagonists for treatment of autoimmune or inflammatory disease
|
US6911321B2
(en)
|
2001-12-19 |
2005-06-28 |
Genentech, Inc. |
Non-human primate Fc receptors and methods of use
|
US20040002587A1
(en)
|
2002-02-20 |
2004-01-01 |
Watkins Jeffry D. |
Fc region variants
|
US7132100B2
(en)
|
2002-06-14 |
2006-11-07 |
Medimmune, Inc. |
Stabilized liquid anti-RSV antibody formulations
|
US7425618B2
(en)
|
2002-06-14 |
2008-09-16 |
Medimmune, Inc. |
Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
|
TW200501985A
(en)
|
2002-07-25 |
2005-01-16 |
Medimmune Inc |
Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies
|
CA2495251C
(fr)
|
2002-08-14 |
2018-03-06 |
Macrogenics, Inc. |
Anticorps specifiques du recepteur fc.gamma.riib et procedes d'utilisation de ces anticorps
|
DK2345671T3
(en)
|
2002-09-27 |
2016-02-15 |
Xencor Inc |
Optimized Fc variants and methods for their formation
|
SI1562972T1
(sl)
|
2002-10-15 |
2010-12-31 |
Facet Biotech Corp |
ALTERACIJA FcRn VEZANIH AFINITET ALI SERUMSKIH RAZPOLOVNIH DOB ANTITELESC Z MUTAGENEZO
|
GB0306618D0
(en)
|
2003-03-22 |
2003-04-30 |
Univ Newcastle |
Antibody
|
WO2006034292A2
(fr)
|
2004-09-21 |
2006-03-30 |
Medimmune, Inc. |
Anticorps dirige contre le virus respiratoire syncytial et procedes de production de vaccins associes
|
CA2585891A1
(fr)
|
2004-10-29 |
2006-05-11 |
Medimmune, Inc. |
Methodes de prevention et de traitement des infections a rsv et des etats pathologiques associes
|
EP1893647A2
(fr)
|
2005-06-23 |
2008-03-05 |
MedImmune, Inc. |
Formulations d'anticorps possedant des profils d'agregation et de fragmentation optimises
|
AU2008209404B2
(en)
|
2007-01-22 |
2012-08-16 |
Genentech, Inc. |
Polyelectrolyte precipitation and purification of antibodies
|
EP2069400A4
(fr)
|
2007-06-26 |
2012-03-07 |
Medimmune Llc |
Procedes de traitement d'infection par le vrs et etats associes
|
BR112015009969A2
(pt)
|
2012-11-05 |
2017-07-11 |
Medimmune Llc |
método de isolamento de synagis® na ausência de benzonase
|